Conference abstract
New class of nanomedicines to image and treat primary and metastatic tumors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nanopolymers are highly promising vehicles for multi-targeting and can provide molecular combination therapy and thus, personalized therapy based on specific marker expression profiles. In our work, a natural nanobiopolymer, polymalic acid (PMLA), was used as a nanoplatform for the family of PolycefinTM drugs to treat primary and metastatic tumors. Treatment efficacy was examined in treatment of primary brain and breast and metastatic tumors with polymer-attached antisense oligonucleotides (AON) to four molecular markers: α and β laminin, EGFR, HER2 and tumor-specific corresponding monoclonal antibodies (mAb) to either EGFR (cetuximab) or HER2 (herceptin), and transferrin receptor (TfR) for delivery through mouse endothelial system including brain blood and tumor barriers (BBB/BTB). In brain tumors treated with polycefin nanobiopolymer bearing AON against chains of tumor vascular protein, laminin-411, the vascular area was significantly decreased and tumor size was reduced 10-fold. For HER2-positive primary breast cancer, more than 90% growth inhibition was achieved in vivo in a mouse model using polycefin-attached HER2 AON. Treatment of primary TNBC by another Polycefin version, where PMLA had anti-TfR mAb for transcytosis, nucleosome-related antigen binding 2C5 mAb for tumor cell targeting, and anti-EGFR AON to block tumor cell growth, also led to a significant reduction of tumor size. Polymer-treated tumors exhibited significant cell apoptosis identified by the cleaved PARP method. Polycefin drugs were also used to treat brain metastases. Animal survival after Polycefin treatment of lung metastasis, HER2- positive breast cancer and TNBC was significantly: 65% for lung cancer, 47% for HER2-positive breast cancer, and 81% for TNBC. Overall, these nanoconjugates showed significant anti-tumor activity to treat primary cancers and metastases to the brain
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Ljubimova J. Y”
- BylineArticles whose byline prints “Patil R”
- BylineArticles whose byline prints “Ding H”
- BylineArticles whose byline prints “Portilla J”
- BylineArticles whose byline prints “Rekechenetskiy A”
- BylineArticles whose byline prints “Bindu K”
- BylineArticles whose byline prints “Markman J”
- BylineArticles whose byline prints “Gangalum P”
